Fig. 1: Study overview and cohort composition.
From: A multimodal uncertainty-aware AI system optimizes ovarian cancer risk assessment workflow
a System development workflow showing the construction, validation and clinical deployment of UMORSS using multimodal data from retrospective and prospective cohorts. b Distribution of pathological categories (physiological cysts, benign, borderline, and malignant tumors) across the four study cohorts.
